Associations between cardiac target organ damage and microvascular dysfunction: The role of blood pressure

Journal of Hypertension

Volumn 28, Issue 5, 2010, Pages 952-958

  Strain, William D ^a   Chaturvedi, Nish ^b   Hughes, Alun ^b   Nihoyannopoulos, Petros ^c   Bulpitt, Christopher J ^c   Rajkumar, Chakravarthi ^d   Shore, Angela C ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b International Centre for Circulatory Health   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

Hypertension; Left ventricular remodelling; Microcirculation; Vascular autoregulation

Indexed keywords

GLUCOSE;

ADULT; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LASER DOPPLER FLOWMETRY; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SKIN BLOOD VESSEL;

EID: 77951297913     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328336ad6c     Document Type: Article

References (43)

1. Mattock MB, Barnes DJ, Viberti G, Keen H, Burt D, Hughes JM, et al. Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes 1998; 47:1786-1792. (Pubitemid 28476254)
2. Ljungman S, Wikstrand J, Hartford M, Berglund G. Urinary albumin excretion: a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 1996; 9:770-778. (Pubitemid 26271222)
3. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in nondiabetic subjects. Islington Diabetes Survey. Lancet 1988; 2:530-533.
4. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19:1992-1997. (Pubitemid 29379934)
5. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286:421-426. (Pubitemid 32681484)
6. Witt N, Wong TY, Hughes AD, Chaturvedi N, Klein BE, Liao DP, et al. Abnormalities of retinal microvascular structure and risk of mortality from ischemic heart disease and stroke. Hypertension 2006; 47:975-981. (Pubitemid 44297571)
7. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002; 288:67-74. (Pubitemid 34705520)
8. Wong TY, Rosamond W, Chang PP, Couper DJ, Sharrett AR, Hubbard LD, et al. Retinopathy and risk of congestive heart failure. JAMA 2005; 293:63-69. (Pubitemid 40066700)
9. Strain WD, Chaturvedi N, Bulpitt CJ, Rajkumar C, Shore AC. Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction? Diabetes 2005; 54:1816-1822. (Pubitemid 40770772)
10. Yamamoto-Suganuma R, Aso Y. Relationship between postocclusive forearm skin reactive hyperaemia and vascular disease in patients with Type 2 diabetes: a novel index for detecting micro-and macrovascular dysfunction using laser Doppler flowmetry. Diabet Med 2009; 26:83-88.
11. Casale PN, Devereux RB, Milner M, Zullo G, Harxhfield GA, Pickering TG, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173. (Pubitemid 16039288)
12. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
13. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117:831-836. (Pubitemid 26014524)
14. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension. J Am Coll Cardiol 1992; 19:1550.
15. Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S. Left ventricular mass and geometry and the risk of ischemic stroke. Stroke 2003; 34:2380-2384. (Pubitemid 37221946)
16. Sierra C, de la Sierra A, Pare JC, Gomez-Angelats E, Coca A. Correlation between silent cerebral white matter lesions and left ventricular mass and geometry in essential hypertension. Am J Hypertens 2002; 15:507-512. (Pubitemid 34596956)
17. Shigematsu Y, Hamada M, Ohtsuka T, Hashida H, Ikeda S, Kuwahara T, et al. Left ventricular geometry as an independent predictor for extracardiac target organ damage in essential hypertension. Am J Hypertens 1998; 11:1171-1177. (Pubitemid 28494179)
18. Pontremoli R, Ravera M, Bezante GP, Viazzi F, Nicolella C, Berruti V, et al. Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 1999; 17:993-1000. (Pubitemid 29322188)
19. Pontremoli R, Leoncini G, Ravera M, Viazzi F, Vettoretti S, Ratto E, et al. Microalbuminuria, cardiovascular, and renal risk in primary hypertension. J Am Soc Nephrol 2002; 13 (Suppl 3):S169-S172. (Pubitemid 35216019)
20. Sundstrom J, Lind L, Nystrom N, Zethelius B, Andren B, Hales CN, et al. Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. Circulation 2000; 101:2595-2600. (Pubitemid 30350637)
21. Schafer S, Kelm M, Mingers S, Strauer BE. Left ventricular remodeling impairs coronary flow reserve in hypertensive patients. J Hypertens 2002; 20:1431-1437. (Pubitemid 34925689)
22. Strain WD, Chaturvedi N, Nihoyannopoulos P, Bulpitt CJ, Rajkumar C, Shore AC. Differences in the association between type 2 diabetes and impaired microvascular function among Europeans and African Caribbeans. Diabetologia 2005; 48:2269-2277. (Pubitemid 41618917)
23. Bone M. Registration with general medical practitioners in inner London: a survey carried out on behalf of the Department of Health and Social Security. London: HMSO; 1984.
24. Chaturvedi N, McKeigue PM. Methods for epidemiological surveys of ethnic minority groups. J Epidemiol Community Health 1994; 48:107-111. (Pubitemid 24148391)
25. Chen CH, Nevo E, Fetics B, Pak PH, Yin FCP, Maughan WL, et al. Estimation of central aortic pressure waveform by mathematical transformation of radical tonometry pressure: validation of generalised transfer function. Circulation 1997; 95:1827. (Pubitemid 27164400)
26. Siebenhofer A, Kemp CRW, Sutton AJ, Williams B. The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocaardiography. J Hum Hypertension 1999; 13:625. (Pubitemid 29438533)
27. Devereux RB, Liebson PR, Horan MJ. Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension 1987; 9:II97-II104.
28. Chaturvedi N, Athanassopoulos G, McKeigue PM, Marmot MG, Nihoyannopoulos P. Echocardiographic measures of left ventricular structure and their relation with rest and ambulatory blood pressure in blacks and whites in the United Kingdom. J Am Coll Cardiol 1994; 24:1499-1505. (Pubitemid 24344246)
29. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25:871.
30. Galderisi M,de Simone G, CicalaS, De Simone L, D'Errico A, Caso P, et al. Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass. J Hypertens 2003; 21:2183-2188. (Pubitemid 38296881)
31. Muiesan ML, Rizzoni D, Salvetti M, Porteri E, Monteduro C, Guelfi D, et al. Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension. J Hypertens 2002; 20:1439-1444. (Pubitemid 34925690)
32. Rizzoni D, Palombo C, Porteri E, Muiesan ML, Kozakova M, La Canna G, et al. Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. J Hypertens 2003; 21:625-631. (Pubitemid 36418976)
33. Gerdts E, Roman MJ, Palmieri V, Wachtell K, Smith G, Nieminen MS, et al. Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study). J Hum Hypertens 2004; 18:417-422. (Pubitemid 38787037)
34. Taniguchi I, Kawai M, Date T, Yoshida S, Seki S, Taniguchi M, et al. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy. Circ J 2006; 70:995-1000. (Pubitemid 44161735)
35. Grandi AM, Solbiati F, Laurita E, Maresca AM, Nicolini E, Marchesi C, et al. Effects of dual blockade of renin-angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study. Am J Hypertens 2008; 21:231-237. (Pubitemid 351231577)
36. Laukkanen JA, Kurl S, Eranen J, Huttunen M, Salonen JT. Left atrium size and the risk of cardiovascular death in middle-aged men. Arch Intern Med 2005; 165:1788-1793. (Pubitemid 41138969)
37. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90:1284-1289.
38. Strain WD, Chaturvedi N, Leggetter S, Nihoyannopoulos P, Rajkumar C, Bulpitt CJ, Shore AC. Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens 2005; 23:133-140. (Pubitemid 40128991)
39. Carlson BE, Arciero JC, Secomb TW. Theoretical model of blood flow autoregulation: roles of myogenic, shear-dependent, and metabolic responses. Am J Physiol Heart Circ Physiol 2008; 295:H1572-H1579.
40. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83:1849-1865.
41. Ahn J, Varagic J, Slama M, Susic D, Frohlich ED. Cardiac structural and functional responses to salt loading in SHR. Am J Physiol Heart Circ Physiol 2004; 287:H767-H772. (Pubitemid 38955311)
42. Schmieder RE, Messerli FH, Ruddel H, Garavaglia GG, Grube E, Nunez BD, Schulte W. Sodium intake modulates left ventricular hypertrophy in essential hypertension. J Hypertens Suppl 1988; 6:S148-S150. (Pubitemid 19067299)
43. Frohlich ED. The salt conundrum: a hypothesis. Hypertension 2007; 50:161-166.